The frequency of EpCAM expression in our western HCC cohort was lower compared to Asian cohorts in which its frequency ranges from 15% to 56% of patients [37], [38], [39], [40], [41], [42], [43]. Here, EPCAM is linked to hepatocellular carcinoma.